Literature DB >> 3190455

The role of phospholipase in plasmocid-induced mitochondrial dysfunction in rat hearts.

N Hieda1, S Sugiyama, Y Ogawa, T Ito, T Satake, T Ozawa.   

Abstract

This study was designed to clarify the role of phospholipase in the mechanism of plasmocid-induced mitochondrial dysfunction in the rat heart. Rats were divided into two groups: the control group, untreated; and the plasmocid group, in which plasmocid (30 mg/kg) was injected subcutaneously. In each group, the level of lipid peroxides and the phospholipase activity in heart homogenate were measured, and mitochondrial function (respiratory control index and the rate of oxygen consumption in State III) was determined polarographically. The activity of lysosomal enzymes (N-acetyl-beta-glucosaminidase and beta-glucuronidase) were also measured. The plasmocid group showed significant increases in lipid peroxide levels and phospholipase activity. Administration of plasmocid also caused mitochondrial dysfunction, while no significant changes were observed in the lysosomal enzyme activity of either group. These results suggested that plasmocid-induced mitochondrial dysfunction is based on the degrading of phospholipids by membrane bound phospholipase, and that lysosomal enzymes are unlikely to be involved in plasmocid-induced mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190455     DOI: 10.1007/bf00316256

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  27 in total

1.  A new technique for isolation of particulate lysosomal activity from canine and rat myocardium.

Authors:  R C Ruth; F F Kennett; W B Weglicki
Journal:  J Mol Cell Cardiol       Date:  1978-08       Impact factor: 5.000

2.  [Z-line alteration in plasmocid-induced myopathy].

Authors:  H Nakase
Journal:  Rinsho Shinkeigaku       Date:  1985-07

3.  Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury.

Authors:  K R Chien; J Abrams; A Serroni; J T Martin; J L Farber
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

4.  Prostaglandin I2 analogue and propranolol prevent ischaemia induced mitochondrial dysfunction through the stabilisation of lysosomal membranes.

Authors:  N Hieda; Y Toki; S Sugiyama; T Ito; T Satake; T Ozawa
Journal:  Cardiovasc Res       Date:  1988-03       Impact factor: 10.787

5.  Initiation of phospholipase A2 activity in human platelets by the calcium ion ionophore A23187.

Authors:  W C Pickett; R L Jesse; P Cohen
Journal:  Biochim Biophys Acta       Date:  1976-01-18

6.  Mechanism of cardiac arrhythmias induced by epinephrine in dogs with hypokalemia.

Authors:  M Ajioka; S Sugiyama; K Ogawa; T Satake; T Ozawa
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

7.  Effect of anthracycline antibiotics on oxygen radical formation in rat heart.

Authors:  J H Doroshow
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

8.  Mechanism of isoproterenol induced myocardial damage.

Authors:  T Kondo; Y Ogawa; S Sugiyama; T Ito; T Satake; T Ozawa
Journal:  Cardiovasc Res       Date:  1987-04       Impact factor: 10.787

9.  Quantitative determination of the fatty acid composition of human serum lipids by high-performance liquid chromatography.

Authors:  Y Shimomura; S Sugiyama; T Takamura; T Kondo; T Ozawa
Journal:  J Chromatogr       Date:  1986-11-28

10.  Role of phospholipase in the genesis of doxorubicin-induced cardiomyopathy in rats.

Authors:  Y Ogawa; T Kondo; S Sugiyama; K Ogawa; T Satake; T Ozawa
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.